| Autor: |
Nsanzimana S; From the Rwanda Biomedical Center, Kigali, Rwanda., McArdle F; From the Rwanda Biomedical Center, Kigali, Rwanda., Remera E; From the Rwanda Biomedical Center, Kigali, Rwanda., Mulindabigwi A; From the Rwanda Biomedical Center, Kigali, Rwanda., Ribakare M; From the Rwanda Biomedical Center, Kigali, Rwanda., Ndimubanzi P; Centers for Disease Control and Prevention-Rwanda, Kigali, Rwanda., Kayirangwa E; Centers for Disease Control and Prevention-Rwanda, Kigali, Rwanda., Baribwira C; Institute of Human Virology and Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD., Riedel DJ; Institute of Human Virology and Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD., Ntaganira J; University of Rwanda, College of Medicine and Health Sciences, School of Public Health, Kigali, Rwanda. |
| Abstrakt: |
Rwanda has made significant progress in expanding pediatric antiretroviral treatment coverage. This was a nationwide, cross-sectional study of pediatric HIV suppression rates. Of 292 children on antiretroviral treatment ≥12 months, 68.8% achieved viral suppression < 40 copies/ml, respectively. Rwanda achieved good pediatric viral suppression rates, comparable to those from other resource-limited settings, yet more efforts are needed to achieve the UNAIDS 90-90-90 target. |
